TY - JOUR AU - Leong, S. R. AU - Sukumaran, S. AU - Hristopoulos, M. AU - Totpal, K. AU - Stainton, S. AU - Lu, E. PY - 2017 DA - 2017// TI - An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemia JO - Blood VL - 129 UR - https://doi.org/10.1182/blood-2016-08-735365 DO - 10.1182/blood-2016-08-735365 ID - Leong2017 ER - TY - JOUR AU - Saygin, C. AU - Carraway, H. E. PY - 2017 DA - 2017// TI - Emerging therapies for acute myeloid leukemia JO - J Hematol Oncol VL - 10 UR - https://doi.org/10.1186/s13045-017-0463-6 DO - 10.1186/s13045-017-0463-6 ID - Saygin2017 ER - TY - JOUR AU - Im, A. AU - Pavletic, S. Z. PY - 2017 DA - 2017// TI - Immunotherapy in hematologic malignancies: past, present, and future JO - J Hematol Oncol VL - 10 UR - https://doi.org/10.1186/s13045-017-0453-8 DO - 10.1186/s13045-017-0453-8 ID - Im2017 ER - TY - JOUR AU - Bakker, A. B. AU - Oudenrijn, S. AU - Bakker, A. Q. AU - Feller, N. AU - Meijer, M. AU - Bia, J. A. PY - 2004 DA - 2004// TI - C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-1659 DO - 10.1158/0008-5472.CAN-04-1659 ID - Bakker2004 ER - TY - JOUR AU - Siveen, K. S. AU - Uddin, S. AU - Mohammad, R. M. PY - 2017 DA - 2017// TI - Targeting acute myeloid leukemia stem cell signaling by natural products JO - Mol Cancer VL - 16 UR - https://doi.org/10.1186/s12943-016-0571-x DO - 10.1186/s12943-016-0571-x ID - Siveen2017 ER - TY - JOUR AU - Yoshida, G. J. AU - Saya, H. PY - 2016 DA - 2016// TI - Therapeutic strategies targeting cancer stem cells JO - Cancer Sci VL - 107 UR - https://doi.org/10.1111/cas.12817 DO - 10.1111/cas.12817 ID - Yoshida2016 ER - TY - JOUR AU - Zhou, J. AU - Chng, W. J. PY - 2014 DA - 2014// TI - Identification and targeting leukemia stem cells: the path to the cure for acute myeloid leukemia JO - World J Stem Cells VL - 6 UR - https://doi.org/10.4252/wjsc.v6.i4.473 DO - 10.4252/wjsc.v6.i4.473 ID - Zhou2014 ER - TY - JOUR AU - Hutten, T. J. AU - Thordardottir, S. AU - Fredrix, H. AU - Janssen, L. AU - Woestenenk, R. AU - Tel, J. PY - 2016 DA - 2016// TI - CLEC12A-mediated antigen uptake and cross-presentation by human dendritic cell subsets efficiently boost tumor-reactive T cell responses JO - J Immunol VL - 197 UR - https://doi.org/10.4049/jimmunol.1600011 DO - 10.4049/jimmunol.1600011 ID - Hutten2016 ER - TY - JOUR AU - Marshall, A. S. AU - Willment, J. A. AU - Pyz, E. AU - Dennehy, K. M. AU - Reid, D. M. AU - Dri, P. PY - 2006 DA - 2006// TI - Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation JO - Eur J Immunol VL - 36 UR - https://doi.org/10.1002/eji.200535628 DO - 10.1002/eji.200535628 ID - Marshall2006 ER - TY - JOUR AU - Chen, C. H. AU - Floyd, H. AU - Olson, N. E. AU - Magaletti, D. AU - Li, C. AU - Draves, K. PY - 2006 DA - 2006// TI - Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-08-3264 DO - 10.1182/blood-2005-08-3264 ID - Chen2006 ER - TY - JOUR AU - Chiffoleau, E. PY - 2018 DA - 2018// TI - C-type lectin-like receptors as emerging orchestrators of sterile inflammation represent potential therapeutic targets JO - Front Immunol VL - 9 UR - https://doi.org/10.3389/fimmu.2018.00227 DO - 10.3389/fimmu.2018.00227 ID - Chiffoleau2018 ER - TY - JOUR AU - Neumann, K. AU - Castineiras-Vilarino, M. AU - Hockendorf, U. AU - Hannesschlager, N. AU - Lemeer, S. AU - Kupka, D. PY - 2014 DA - 2014// TI - Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell death JO - Immunity VL - 40 UR - https://doi.org/10.1016/j.immuni.2013.12.015 DO - 10.1016/j.immuni.2013.12.015 ID - Neumann2014 ER - TY - JOUR AU - Marshall, A. S. AU - Willment, J. A. AU - Lin, H. H. AU - Williams, D. L. AU - Gordon, S. AU - Brown, G. D. PY - 2004 DA - 2004// TI - Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M313127200 DO - 10.1074/jbc.M313127200 ID - Marshall2004 ER - TY - JOUR AU - Billadeau, D. D. AU - Leibson, P. J. PY - 2002 DA - 2002// TI - ITAMs versus ITIMs: striking a balance during cell regulation JO - J Clin Invest VL - 109 UR - https://doi.org/10.1172/JCI0214843 DO - 10.1172/JCI0214843 ID - Billadeau2002 ER - TY - JOUR AU - Darwish, N. H. AU - Sudha, T. AU - Godugu, K. AU - Elbaz, O. AU - Abdelghaffar, H. A. AU - Hassan, E. E. PY - 2016 DA - 2016// TI - Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1 JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.11063 DO - 10.18632/oncotarget.11063 ID - Darwish2016 ER - TY - JOUR AU - Robinson, M. J. AU - Sancho, D. AU - Slack, E. C. AU - LeibundGut-Landmann, S. AU - Reis e Sousa, C. PY - 2006 DA - 2006// TI - Myeloid C-type lectins in innate immunity JO - Nat Immunol VL - 7 UR - https://doi.org/10.1038/ni1417 DO - 10.1038/ni1417 ID - Robinson2006 ER - TY - JOUR AU - Wu, H. AU - Windmiller, D. A. AU - Wang, L. AU - Backer, J. M. PY - 2003 DA - 2003// TI - YXXM motifs in the PDGF-beta receptor serve dual roles as phosphoinositide 3-kinase binding motifs and tyrosine-based endocytic sorting signals JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.C300225200 DO - 10.1074/jbc.C300225200 ID - Wu2003 ER - TY - JOUR AU - Songyang, Z. AU - Shoelson, S. E. AU - Chaudhuri, M. AU - Gish, G. AU - Pawson, T. AU - Haser, W. G. PY - 1993 DA - 1993// TI - SH2 domains recognize specific phosphopeptide sequences JO - Cell VL - 72 UR - https://doi.org/10.1016/0092-8674(93)90404-E DO - 10.1016/0092-8674(93)90404-E ID - Songyang1993 ER - TY - JOUR AU - Zhao, X. AU - Singh, S. AU - Pardoux, C. AU - Zhao, J. AU - Hsi, E. D. AU - Abo, A. PY - 2010 DA - 2010// TI - Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia JO - Haematologica VL - 95 UR - https://doi.org/10.3324/haematol.2009.009811 DO - 10.3324/haematol.2009.009811 ID - Zhao2010 ER - TY - JOUR AU - Gagne, V. AU - Marois, L. AU - Levesque, J. M. AU - Galarneau, H. AU - Lahoud, M. H. AU - Caminschi, I. PY - 2013 DA - 2013// TI - Modulation of monosodium urate crystal-induced responses in neutrophils by the myeloid inhibitory C-type lectin-like receptor: potential therapeutic implications JO - Arthritis Res Ther VL - 15 UR - https://doi.org/10.1186/ar4250 DO - 10.1186/ar4250 ID - Gagne2013 ER - TY - JOUR AU - Sagar, D. AU - Singh, N. P. AU - Ginwala, R. AU - Huang, X. AU - Philip, R. AU - Nagarkatti, M. PY - 2017 DA - 2017// TI - Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-03027-x DO - 10.1038/s41598-017-03027-x ID - Sagar2017 ER - TY - JOUR AU - Michou, L. AU - Cornelis, F. AU - Levesque, J. M. AU - Bombardieri, S. AU - Balsa, A. AU - Westhovens, R. PY - 2012 DA - 2012// TI - A genetic association study of the CLEC12A gene in rheumatoid arthritis JO - Joint Bone Spine VL - 79 UR - https://doi.org/10.1016/j.jbspin.2011.12.012 DO - 10.1016/j.jbspin.2011.12.012 ID - Michou2012 ER - TY - JOUR AU - Redelinghuys, P. AU - Whitehead, L. AU - Augello, A. AU - Drummond, R. A. AU - Levesque, J. M. AU - Vautier, S. PY - 2016 DA - 2016// TI - MICL controls inflammation in rheumatoid arthritis JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2014-206644 DO - 10.1136/annrheumdis-2014-206644 ID - Redelinghuys2016 ER - TY - JOUR AU - Begun, J. AU - Lassen, K. G. AU - Jijon, H. B. AU - Baxt, L. A. AU - Goel, G. AU - Heath, R. J. PY - 2015 DA - 2015// TI - Integrated genomics of Crohn's disease risk variant identifies a role for CLEC12A in antibacterial autophagy JO - Cell Rep VL - 11 UR - https://doi.org/10.1016/j.celrep.2015.05.045 DO - 10.1016/j.celrep.2015.05.045 ID - Begun2015 ER - TY - JOUR AU - Fresno, C. AU - Iborra, S. AU - Saz-Leal, P. AU - Martinez-Lopez, M. AU - Sancho, D. PY - 2018 DA - 2018// TI - Flexible signaling of myeloid C-type lectin receptors in immunity and inflammation JO - Front Immunol VL - 9 UR - https://doi.org/10.3389/fimmu.2018.00804 DO - 10.3389/fimmu.2018.00804 ID - Fresno2018 ER - TY - JOUR AU - Hoving, J. C. AU - Wilson, G. J. AU - Brown, G. D. PY - 2014 DA - 2014// TI - Signalling C-type lectin receptors, microbial recognition and immunity JO - Cell Microbiol VL - 16 UR - https://doi.org/10.1111/cmi.12249 DO - 10.1111/cmi.12249 ID - Hoving2014 ER - TY - JOUR AU - Pyz, E. AU - Huysamen, C. AU - Marshall, A. S. AU - Gordon, S. AU - Taylor, P. R. AU - Brown, G. D. PY - 2008 DA - 2008// TI - Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand JO - Eur J Immunol VL - 38 UR - https://doi.org/10.1002/eji.200738057 DO - 10.1002/eji.200738057 ID - Pyz2008 ER - TY - JOUR AU - Wang, J. AU - Chen, S. AU - Xiao, W. AU - Li, W. AU - Wang, L. AU - Yang, S. PY - 2018 DA - 2018// TI - CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia JO - J Hematol Oncol VL - 11 UR - https://doi.org/10.1186/s13045-017-0553-5 DO - 10.1186/s13045-017-0553-5 ID - Wang2018 ER - TY - JOUR AU - Toft-Petersen, M. AU - Stidsholt Roug, A. AU - Plesner, T. AU - Ebbesen, L. AU - Brown, G. D. AU - Nederby, L. PY - 2018 DA - 2018// TI - The CLEC12A receptor marks human basophils: potential implications for minimal residual disease detection in acute myeloid leukemia JO - Cytometry B Clin Cytom VL - 94 UR - https://doi.org/10.1002/cyto.b.21540 DO - 10.1002/cyto.b.21540 ID - Toft-Petersen2018 ER - TY - JOUR AU - Bill, M. a. r. i. e. AU - B. van Kooten Niekerk, P. e. t. e. r. AU - S. Woll, P. e. t. t. e. r. AU - Laine Herborg, L. a. u. r. a. AU - Stidsholt Roug, A. n. n. e. AU - Hokland, P. e. t. e. r. AU - Nederby, L. i. n. e. PY - 2018 DA - 2018// TI - Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A-related cancer stem cell biology JO - Journal of Cellular and Molecular Medicine VL - 22 UR - https://doi.org/10.1111/jcmm.13519 DO - 10.1111/jcmm.13519 ID - Bill2018 ER - TY - JOUR AU - Tashiro, H. AU - Sauer, T. AU - Shum, T. AU - Parikh, K. AU - Mamonkin, M. AU - Omer, B. PY - 2017 DA - 2017// TI - Treatment of acute myeloid leukemia with T cells expressing chimeric antigen receptors directed to C-type lectin-like molecule 1 JO - Mol Ther VL - 25 UR - https://doi.org/10.1016/j.ymthe.2017.05.024 DO - 10.1016/j.ymthe.2017.05.024 ID - Tashiro2017 ER - TY - JOUR AU - Rhenen, A. AU - Dongen, G. A. AU - Kelder, A. AU - Rombouts, E. J. AU - Feller, N. AU - Moshaver, B. PY - 2007 DA - 2007// TI - The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2007-03-083048 DO - 10.1182/blood-2007-03-083048 ID - Rhenen2007 ER - TY - JOUR AU - Larsen, H. O. AU - Roug, A. S. AU - Just, T. AU - Brown, G. D. AU - Hokland, P. PY - 2012 DA - 2012// TI - Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up JO - Cytometry B Clin Cytom VL - 82 UR - https://doi.org/10.1002/cyto.b.20614 DO - 10.1002/cyto.b.20614 ID - Larsen2012 ER - TY - JOUR AU - Eissa, D. S. AU - Kandeel, E. Z. AU - Ghareeb, M. PY - 2017 DA - 2017// TI - Human myeloid inhibitory C-lectin: a highly specific and stable acute myeloid leukemia marker JO - Hematol Oncol VL - 35 UR - https://doi.org/10.1002/hon.2352 DO - 10.1002/hon.2352 ID - Eissa2017 ER - TY - STD TI - Coustan-Smith E, Song G, Shurtleff S, Yeoh AE, Chng WJ, Chen SP, et al. Universal monitoring of minimal residual disease in acute myeloid leukemia. JCI Insight. 2018;3(9): e98561. ID - ref35 ER - TY - JOUR AU - Rhenen, A. AU - Moshaver, B. AU - Kelder, A. AU - Feller, N. AU - Nieuwint, A. W. AU - Zweegman, S. PY - 2007 DA - 2007// TI - Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission JO - Leukemia VL - 21 UR - https://doi.org/10.1038/sj.leu.2404754 DO - 10.1038/sj.leu.2404754 ID - Rhenen2007 ER - TY - JOUR AU - Rhenen, A. AU - Feller, N. AU - Kelder, A. AU - Westra, A. H. AU - Rombouts, E. AU - Zweegman, S. PY - 2005 DA - 2005// TI - High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-0468 DO - 10.1158/1078-0432.CCR-05-0468 ID - Rhenen2005 ER - TY - JOUR AU - Terwijn, M. AU - Zeijlemaker, W. AU - Kelder, A. AU - Rutten, A. P. AU - Snel, A. N. AU - Scholten, W. J. PY - 2014 DA - 2014// TI - Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0107587 DO - 10.1371/journal.pone.0107587 ID - Terwijn2014 ER - TY - JOUR AU - Roug, A. S. AU - Larsen, H. O. AU - Nederby, L. AU - Just, T. AU - Brown, G. AU - Nyvold, C. G. PY - 2014 DA - 2014// TI - hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia JO - Br J Haematol VL - 164 UR - https://doi.org/10.1111/bjh.12614 DO - 10.1111/bjh.12614 ID - Roug2014 ER - TY - JOUR AU - Harrington, A. M. AU - Olteanu, H. AU - Kroft, S. H. PY - 2012 DA - 2012// TI - A dissection of the CD45/side scatter “blast gate” JO - Am J Clin Pathol VL - 137 UR - https://doi.org/10.1309/AJCPN4G1IZPABRLH DO - 10.1309/AJCPN4G1IZPABRLH ID - Harrington2012 ER - TY - JOUR AU - Zheng, B. AU - Yu, S. F. AU - Rosario, G. AU - Leong, S. R. AU - Lee, G. Y. AU - Vij, R. PY - 2019 DA - 2019// TI - An anti-CLL-1 antibody-drug conjugate for the treatment of acute myeloid leukemia JO - Clin Cancer Res VL - 25 UR - https://doi.org/10.1158/1078-0432.CCR-18-0333 DO - 10.1158/1078-0432.CCR-18-0333 ID - Zheng2019 ER - TY - JOUR AU - Leipold, D. o. u. g. l. a. s. D. AU - Figueroa, I. s. a. b. e. l. AU - Masih, S. h. a. b. k. h. a. i. z. AU - Latifi, B. r. a. n. d. o. n. AU - Yip, V. i. c. t. o. r. AU - Shen, B. e. n. -. Q. u. a. n. AU - Dere, R. a. n. d. a. l. l. C. AU - Carrasco-Triguero, M. o. n. t. s. e. r. r. a. t. AU - Lee, M. V. i. o. l. e. t. AU - Saad, O. l. a. M. AU - Liu, L. u. n. a. AU - He, J. i. n. t. a. n. g. AU - Su, D. i. a. n. AU - Xu, K. e. y. a. n. g. AU - Vuillemenot, B. r. i. a. n. R. AU - Laing, S. t. e. v. e. n. T. AU - Schutten, M. e. l. i. s. s. a. AU - Kozak, K. a. t. h. e. r. i. n. e. R. AU - Zheng, B. i. n. g. AU - Polson, A. n. d. r. e. w. G. AU - Kamath, A. m. r. i. t. a. V. PY - 2018 DA - 2018// TI - Preclinical pharmacokinetics and pharmacodynamics of DCLL9718A: An antibody-drug conjugate for the treatment of acute myeloid leukemia JO - mAbs VL - 10 UR - https://doi.org/10.1080/19420862.2018.1517565 DO - 10.1080/19420862.2018.1517565 ID - Leipold2018 ER - TY - JOUR AU - Jiang, Y. P. AU - Liu, B. Y. AU - Zheng, Q. AU - Panuganti, S. AU - Chen, R. AU - Zhu, J. PY - 2018 DA - 2018// TI - CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia JO - Blood Adv VL - 2 UR - https://doi.org/10.1182/bloodadvances.2018020107 DO - 10.1182/bloodadvances.2018020107 ID - Jiang2018 ER - TY - JOUR AU - Wiersma, V. R. AU - Bruyn, M. AU - Shi, C. AU - Gooden, M. J. AU - Wouters, M. C. PY - 2015 DA - 2015// TI - Samplonius DF, et al. . C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity JO - MAbs VL - 7 UR - https://doi.org/10.1080/19420862.2015.1007811 DO - 10.1080/19420862.2015.1007811 ID - Wiersma2015 ER - TY - JOUR AU - Wu, J. AU - Fu, J. AU - Zhang, M. AU - Liu, D. PY - 2015 DA - 2015// TI - Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia JO - J Hematol Oncol VL - 8 UR - https://doi.org/10.1186/s13045-015-0195-4 DO - 10.1186/s13045-015-0195-4 ID - Wu2015 ER - TY - JOUR AU - Lu, H. AU - Zhou, Q. AU - Deshmukh, V. AU - Phull, H. AU - Ma, J. AU - Tardif, V. PY - 2014 DA - 2014// TI - Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemia JO - Angew Chem Int Ed Engl VL - 53 UR - https://doi.org/10.1002/anie.201405353 DO - 10.1002/anie.201405353 ID - Lu2014 ER - TY - JOUR AU - Loo, P. F. V. D. R. AU - Dolstra, H. AU - Shamsili, S. AU - Bakker, L. PY - 2015 DA - 2015// TI - Preclinical evaluation of MCLA117, a CLEC12AxCD3 bispecific antibody efficiently targeting a novel leukemic stem cell associated antigen in AML JO - blood VL - 126 ID - Loo2015 ER - TY - JOUR AU - Macri, C. AU - Dumont, C. AU - Panozza, S. AU - Lahoud, M. H. AU - Caminschi, I. AU - Villadangos, J. A. PY - 2017 DA - 2017// TI - Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes JO - Mol Immunol VL - 81 UR - https://doi.org/10.1016/j.molimm.2016.12.010 DO - 10.1016/j.molimm.2016.12.010 ID - Macri2017 ER - TY - JOUR AU - Lahoud, M. H. AU - Proietto, A. I. AU - Ahmet, F. AU - Kitsoulis, S. AU - Eidsmo, L. AU - Wu, L. PY - 2009 DA - 2009// TI - The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses JO - J Immunol VL - 182 UR - https://doi.org/10.4049/jimmunol.0900464 DO - 10.4049/jimmunol.0900464 ID - Lahoud2009 ER - TY - JOUR AU - Laborda, E. d. u. a. r. d. o. AU - Mazagova, M. a. g. d. a. l. e. n. a. AU - Shao, S. i. d. a. AU - Wang, X. i. n. x. i. n. AU - Quirino, H. e. r. l. i. n. d. a. AU - Woods, A. s. h. l. e. y. AU - Hampton, E. r. i. c. AU - Rodgers, D. a. v. i. d. AU - Kim, C. h. a. n. AU - Schultz, P. e. t. e. r. AU - Young, T. r. a. v. i. s. PY - 2017 DA - 2017// TI - Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia JO - International Journal of Molecular Sciences VL - 18 UR - https://doi.org/10.3390/ijms18112259 DO - 10.3390/ijms18112259 ID - Laborda2017 ER - TY - JOUR AU - Kenderian, S. S. R. M. AU - Shestova, O. AU - Klichinsky, M. AU - Kim, M. Y. AU - Soderquist, C. AU - Bagg, A. AU - Singh, R. AU - Richardson, C. AU - Young, R. M. AU - June, C. H. AU - Gill, S. I. PY - 2016 DA - 2016// TI - Leukemia Stem Cells Are Characterized By CLEC12A Expression and Chemotherapy Refractoriness That Can be Overcome By Targeting with Chimeric Antigen Receptor T Cells JO - Blood VL - 128 ID - Kenderian2016 ER - TY - JOUR AU - Togni, E. D. K. M. AU - Cooper, M. L. AU - Ritchey, J. AU - O'Neal, J. AU - Niswonger, J. AU - DiPersio, J. F. PY - 2018 DA - 2018// TI - Chimeric antigen receptor T cells specific for CLL-1 for treatment of acute myeloid leukemia JO - Blood VL - 132 ID - Togni2018 ER - TY - STD TI - Liu F, Pinz K, Ma Y, Wada M, Chen K, Ma G, et al. First-in-human CLL1-CD33 compound CAR T cells as a two-pronged approach for the treatment of refractory acute myeloid leukemia. HemaSphere. 2018;2(S1):29. ID - ref53 ER - TY - JOUR AU - Liu, F. AU - Cao, Y. AU - Pinz, K. AU - Ma, Y. AU - Wada, M. AU - Chen, K. PY - 2018 DA - 2018// TI - First-in-human CLL1-CD33 compound CAR-T cell therapy induces complete remission in patients with refractory acute myeloid leukemia: update on phase 1 clinical trial JO - Blood VL - 132 ID - Liu2018 ER - TY - JOUR AU - Zhao, J. AU - Lin, Q. AU - Song, Y. AU - Liu, D. PY - 2018 DA - 2018// TI - Universal CARs, universal T cells, and universal CAR T cells JO - J Hematol Oncol VL - 11 UR - https://doi.org/10.1186/s13045-018-0677-2 DO - 10.1186/s13045-018-0677-2 ID - Zhao2018 ER - TY - JOUR AU - Zhang, C. AU - Liu, J. AU - Zhong, J. F. AU - Zhang, X. PY - 2017 DA - 2017// TI - Engineering CAR-T cells JO - Biomark Res VL - 5 UR - https://doi.org/10.1186/s40364-017-0102-y DO - 10.1186/s40364-017-0102-y ID - Zhang2017 ER -